Trends of congenital hypothyroidism and inborn errors of metabolism in Pakistan
Orphanet Journal of Rare Diseases volume 15, Article number: 321 (2020)
Metabolic disorders are heterogeneous group of genetic disorders that are responsible for significant neonatal and infant morbidity and mortality worldwide. In developing countries like Pakistan where infant mortality is high current population based studies are unable to gauge contribution of metabolic disorders in causing mortality and morbidity. It is essential to address this gap by a review of available scattered Pakistani data related to metabolic disorders specifically congenital hypothyroidism and inborn error of metabolism to calculate probable burden of these disorders.
Unfortunately currently in Pakistan newborn screening which identifies these illnesses at birth as a preventive strategy are not available. For current review data was collected through a systematic search of published articles (including data related to screening in certain subgroups of patients admitted to pediatric/neonatal intensive care units, patients with developmental delay/mental retardation).
The primary aim of this review was to get an estimate of the disease burden in the Pakistani population as true prevalence of Congenital Hypothyroidism and Inborn Errors of Metabolism in Pakistan is not available. This systematic review will help us to identify the rough idea about the scale of problem in Pakistan.
Metabolic disorders like congenital hypothyroidism (CH) and inborn errors of metabolism (IEM) are considerable cause of disease and death among children in both the advance and developing nations of the world with the prevalence of CH is about 1 per 3000–4000 and IEM is 1 in 800–2500 births in West [1, 2]. Metabolic disorders are genetically inherited biochemical disorders of specific enzymes or proteins causing a block in a normal metabolic process of protein, carbohydrate or fat metabolism. Classification is challenging as it can occur in every biochemical pathway. Based on pathophysiology, there are three main sub groups of IEM; conditions that cause intoxication, conditions of energy metabolism and conditions of complex molecules . Severity of the symptoms experienced by affected individuals of IEM varies relying on the genetic and mutation history . Due to absence of neonatal screening facilities in Pakistan children born with IEMs are usually diagnosed on the basis of clinical symptoms including lethargy, poor feeding, apnea or tachypnea, and recurrent vomiting. That makes it difficult to manage childhood morbidity and mortality due to these disorders in an effective manner. Multiple studies in selected scattered groups of Pakistani patients have confirmed the high prevalence of IEMs is due to the high rate of inter-marriages and large family sizes . To classify CH we can use etiological basis of disease according to which there are two main categories of these disorders (a) disorders of thyroid gland development (Group of dysembriogenesis or thyroid dysgenesis) or (b) defects in any of the steps of thyroid hormone synthesis (group of dyshormonogenesis) [6, 7].
Status of IEM diagnosis and management in Pakistan
Though some information regarding mental retardation and new born screening (NBS) for CH in Pakistani population is available since 1987, but a true prevalence of IEM is yet to be determined [5, 8]. Relative or true incidence of IEM in the population or even among the critically ill newborns through systematic reviews is lacking as NBS is not available in Pakistan. Mostly IEM is diagnosed either through biochemical tests on specific population mostly pediatric population. Mostly studies have bias of screening for IEM in high risk patients either in intensive care of pediatrics or medicine .
To determine true prevalence of IEM in Pakistan one important and ideal strategy needs to be applied, i.e., Prospective data collection from a universal and expanded screening of a low risk population. Mass spectrometry is considered to be ideal for screening metabolic IEM but very few centers in Pakistan are offering these services either in collaboration with tertiary care hospitals of Pakistan or abroad for few large cities [5, 10, 11].
Material and methods
The purpose of this study was to learn about the various forms of metabolic disorders across Pakistani population. For current review data was collected through a systematic search of published articles on metabolic disorders including congenital hypothyroidism and inborn error of metabolism among Pakistani population. Data related to screening in certain subgroups of patients admitted to pediatric/neonatal intensive care units, patients with developmental delay/mental retardation was included. Studies from Pakistan in which metabolic disorders were evaluated for the markers, technologies and modalities to reach the diagnosis were specifically included. Search was done to find any possible study with published data considering the overall prevalence of metabolic disorders in general population of Pakistan. For the current project unpublished data or data from institutions was not collected at national or individual hospital levels performing CH and IEM related biochemical or genetic tests locally or abroad. Studies, in which probability of IEM was not confirmed by biochemical or molecular testing, were excluded. Data from all studies included in this review was summarized to obtain an overall picture of the selected disease burden from studies based on selected subgroups (Tables 1, 2) and from studies mentioning about various forms of IEM (Table 2).
Data related to studies
Based on review of these studies data we were be able to include total of 19 IEM specific studies 8 with CH and 11 mentioning about various forms of IEM in a single article. Out of 19 studies related to IEM five were regarding congenital adrenal hyperplasia (CAH) mainly focusing about the diagnosis, research and management based findings. Eight studies were about lysosomal storage disorders, three were about carbohydrate storage disorders including Galactosemia, Glycogen storage disorders, Fructose 1, 6, Bisphosphate. Two studies specifically mentioning about organic acidemia and one about disorders of aminoaciduria. Total numbers of patients mentioned in various studies were found to be around 313. Out of which 78 patients with carbohydrate storage disorder, 66 with lysosomal storage disorder, 47 with organic acidemia and aminoaciduria and 122 with congenital adrenal hyperplasia. In almost all studies biochemical analysis was discussed to reach the diagnosis but significant delay in diagnosis was due to lack of specific diagnostic facilities. Eleven studies specifically mentioned about the use of genetic test for research purpose. Few basic genetic based diagnostic tests done in Pakistan like PCR, RFLP. But sequencing based data mentioned in studies usually obtained from the international labs working in collaboration with academic institutions. None of the study mentioned regarding the availability or use of advance forms of management options like gene editing etc. (Table 1).
8 studies specifically discussed about congenital hypothyroidism. Seven were on biochemical profile of patients and in one survey tool was designed and implemented to collect data from 400 multiparous women. Number of Patients with congenital hypothyroidism tested through biochemical analysis was 212. None of these studies mentioned about genetic tests use and availability for patients with CH (Table 2).
In 11 studies disorders were investigated with the aim to find about various varieties of IEM. Total number of patients were about 536 including 188 patients from various types of carbohydrate storage disorders like Galactosemia, Glycogen storage disorders, 188 with Lysosomal storage disorders including Mucopolysaccharidosis. 220 with organic acidemia, 64 with Aminoacid disorder, alkaptnuria, tyriosinemia. 4 were with congenital adrenal hyperplasia, 7 with FA oxidation and Carnitine defect, 7 with Ketogenesis and ketolytic defect and 19 with various forms of IEM. Biochemical Analysis was done in all while genetic analysis was not available in any study (Table 2).
According to this data we can say that access to Screening is primarily available at a cost from private laboratories within Pakistan and abroad [5, 10, 11]. Through tandem-MS technology we can simultaneously test for more than 40 disorders. Conventional methods help us to diagnose common disorders like CH, congenital adrenal hyperplasia (CAH) and Galactosemia etc. DNA based testing is not freely available for screening and diagnosis. Few research institutes in Pakistan are working with international collaboration and they are offering genetic tests for few common disorders wherein causal gene is already known [12,13,14,15,16,17]. But for a proportion of IEM, the causal gene or the mutations in various genes remain to be identified in our ethnic population and thus newborn screening (NBS) program encompasses a strong research component as well .
In Pakistan earliest reports of IEM have been far and rare and mostly based on testing newborns with suspicion of IEM or referred to tertiary care centers for intensive care. Some studies included group of subjects who were tested for intellectual disability (Tables 1, 2) . A number of studies from different centers and universities in Pakistan have considered the Pakistani population in the last 15 years for biochemical and genetic analysis and have diagnosed congenital hypothyroidism (CH), condential adrena hyperplasia (CAH), carbohydrate storage disorders, lysosomal storage disorders and organic acidemias (Tables 1, 2). These disorders have been tested at a number of centers, and samples mostly collected from intensive care departments, pediatric units and from hematology units of tertiary care hospitals in Pakistan including Karachi, Lahore, Islamabad, Peshawar and Faisalabad. Mostly patients referred to these centers for diagnosis and better management [5, 12,13,14,15] (Tables 1, 2). It is apparent from the data compiled and presented that there is a need for establishing/identifying reliable labs for biochemical testing and genetic confirmation and taken together, warrant formulation of a standard protocol for testing and follow up of IEM positive cases in the country.
In summary, the present findings suggest that expanded NBS for all treatable and untreatable IEM is carried out at a very few centers in the country; NBS for common treatable conditions namely CH and few organic academia are being carried out in a limited number of hospitals at a few places such as Islamabad, Karachi and Faisalabad in pediatric cohorts with index of suspicion of IEM [5, 8, 10, 11]. Patients are tested on referral at several hospitals/private testing labs in the country; but epidemiological data for all the testable or untreatable IEM in Pakistan are not yet available.
Keeping the genetic landscape of the Pakistani population (for example diversity) combined with socio-cultural practices (for example consanguinity), the need to carry out systematic prospective expanded screening for IEM in each of the Pakistani province to identify the prevalent disorders is imminent. Finally, ongoing and future prospective studies in Pakistan will be useful with moderate sample size in the country which will provide the much needed epidemiological data for this large group of genetic disorders. In future we must try to overcome challenges of IEM in our country including new born screening (NBS). Findings from these studies from different regions of Pakistan will help Pakistan’s health policy makers to mandate universal and expanded NBS in different provinces in the country.
Availability of data and materials
Inborn errors of metabolism
New born screening
Congenital adrenal hyperplasia
Chen CY, Lee KT, Lee CTC, Lai WT, Huang YB. Epidemiology and clinical characteristics of congenital hypothyroidism in an Asian population: a nationwide population-based study. JOE. 2013;2013(23):85–94.
Sanderson S, Green A, Preece MA, et al. The incidence of inherited metabolic disorders in the West Midlands. UK Arch Dis Child. 2006;91:896–9.
Alfadhel M, Babiker A. Inborn errors of metabolism associated with hyperglycaemic ketoacidosis and diabetes mellitus: narrative review. Sudan J Paediatr. 2018;18(1):10–23.
Yubero D, Brandi N, Ormazabal A, Garcia-Cazorla A, Pérez-Dueñas B, Campistol J, Ribes A, Palau F, Artuch R, Armstrong J. Targeted next generation sequencing in patients with inborn errors of metabolism. PLoS ONE. 2016;11:e0156359.
Afroze B, Lakhani L, Naz F, Somani S, Zabedah Md, Yunus NB. Challenges identified in the management of patients with inherited metabolic disorders—a five year Experience from Pakistan. Egypt J Med Hum Genet. 2016;17:259–64.
Léger J, Olivieri A, Donaldson M, Torresani T, Krude H, Van Vliet G, Butler G. European Society for Paediatric Endocrinology consensus guidelines on screening, diagnosis, and management of congenital hypothyroidism. JCEM. 2014;99:363–84.
Thyrotropin Secretion Patterns in Health and Disease Ferdinand Roelfsema and Johannes D. Veldhuis. (2013). ER 34:619–657
Lakhani M, Khurshid M, Naqvi SH, Akber MAD. Neonatal screening for congenital hypothyroidism in Pakistan. JPMA. 1989;39(11):282–4.
Cheema HA, Malik HS, Parkash A, Fayyaz Z. Spectrum of inherited metabolic disorders in Pakistani children presenting at a tertiary care centre. J Coll Phys Surg Pak. 2016;26(6):498–502.
Syeda SG, Ayesha IM, Abida F. Inborn errors of metabolism in newborns: an experience of tertiary care hospital in Islamabad. Ann Pak Inst Med Sci. 2017;13(2):213–6.
Wasim M, Khan HN, Ayesha H, Goorden SMI, Vaz FM, Van Karnebeek CDM, Awan FR. Biochemical screening of intellectually disabled patients: a stepping stone to initiate a newborn screening program in Pakistan. Front Neurol. 2019;10:762.
Zahoor MY, Cheema HA, Ijaz S, Fayyaz Z. Genetic analysis of tyrosinemia type 1 and fructose-1, 6 bisphosphatase deficiency affected Pakistani cohorts. Fetal Pediat Pathol. 2019. https://doi.org/10.1080/15513815.2019.1672224.
Mahmood U, Imran M, Naik SI, Cheema HA, Saeed A, Arshad M, Mahmood S. Detection of common mutations in the GALT gene through ARMS. Gene. 2012;509(2):291–4. https://doi.org/10.1016/j.gene.2012.08.010.
Naz A, Abedin Q, Ahmed S, Siddiqui S, Shamsi T. Identification of GBA gene mutations in 19 Pakistani unrelated patients of Gaucher disease. Blood. 2018a;132:4952. https://doi.org/10.1182/blood-2018-99-12038.
Cheema HA, Rasool IG, Anjum MN, Zahoor MY. Mutational spectrum of SMPD1 gene in Pakistani Niemann-Pick disease patients. Pak J Med Sci. 2020;36(3):479–84. https://doi.org/10.12669/pjms.36.3.467.
Ullah I. Identification and in silico analysis of GALNS mutations causing Morquio A syndrome in eight consanguineous families. Turk J Biol. 2017;41:458–68.
Zahoor MY, Cheema HA, Bhinder MA. Mapping of IDUA gene variants in Pakistani patients with mucopolysaccharidosis type 1. J Pediat Endocrinol Metab. 2019;32(11):1221–7.
Khan AH, Nasir MI, Moatter T. Characterization of pathogenic mutations in 21-hydroxylase gene of Pakistani patients with congenital adrenal hyperplasia—a preliminary report. J Pak Med Assoc. 2002;52:287–91.
Bhanji R, Khan AH, Balouch IL, Sabir S, Nazir Z, Billoo AG. Profile of children with congenital adrenal hyperplasia—a hospital study. J Pak Med Assoc. 2004;54:509–12.
Khan AH, Aban M, Hassan RU, Haq NU, Raza J, Jabbar A, Moatter T. Classic virilizing congenital adrenal hyperplasia presenting late: case series from Pakistan. J Pak Med Assoc. 2009;59:643–6.
Ali CS, Hashim R, Khan F, Ali S. Congenital adrenal hyperplasia (CAH): presentation with ambiguous genitalia s. Pak Armed Forces Med J. 2010;60(3):482–4.
Khan AH, Aban M, Raza J, et al. Ethnic disparity in 21-hydroxylase gene mutations identified in Pakistani congenital adrenal hyperplasia patients. BMC Endocr Disord. 2011;11:5. https://doi.org/10.1186/1472-6823-11-5.
Shah U, Nadeem N, Husen Y, Fadoo Z. Case report imiglucerase treatment in Gaucher’s. Disease. 2007;19(2):56–9.
Chand P, Ibrahim S, Habib B, Jan F. An unusual presentation of neurononopathic gauchers Disease. Pak J Neurol Sci (PJNS). 2013;8(3):4.
Khan K, Farooq N, Raziq F, Ullah H. Hematological presentation of lysosomal storage disorders. RMJ. 2014;39(1):28–31.
Naz A, Abedin Q, Ahmed S, Siddiqui S, Shamsi T. Blood identification of GBA gene mutations in 19 Pakistani unrelated patients of Gaucher. Disease. 2018b;132:4952. https://doi.org/10.1182/blood-2018-99-12038.
Mazher W, Ali* J, Abubakar* S, Basar* S, Murtaza G. Improvement in symptoms of gaucher’s disease by Enzyme replacement therapy Civil Hospital Karachi, *Dow university of Health Sciences, Karachi-Pakistan. J Ayub Med Coll Abbottabad. 2018;30:3.
Cheema HA, Cheema HA, Rasool IG, Anjum MN, Zahoor MY. Mutational spectrum of SMPD1 gene in Pakistani Niemann-Pick disease patients. Pak J Med Sci. 2020;36(3):479–84.
Ullah, I. (2017). In silico analysis of GALNS mutations identified in fifty six Pakistani individuals with Morquio A syndrome, (April). https://doi.org/10.13140/RG.2.2.11622.63041
Hassan Suleman Malik H, Arshad Cheema H, Fayyaz Z, Parkash A, Mushtaq I, Anwar A, Waheed N (2015). Galactosemia: clinical manifestations, diagnosis and outcome of early management. Inst Med Sci. 11(4), 190–194. Retrieved from https://apims.net/apims_old/Volumes/Vol11-4/Galactosemia_ClinicalManifestations.pdf
Saeed A, Arshad* H, Alvi** A, Suleman H. Clinical presentation and biochemical findings in children with Glycogen storage disease type 1a. Pak Armed Forces Med J. 2015;65(5):682–5.
Majid H, Khan AH, Jafri L, Jamil A, Yousufzai N, Fatima M, Ali ZZ, Afroze B. Diagnostic dilemma of patients with methylmalonic aciduria: Experience from a tertiary care centre in Pakistan. J Pak Med Assoc. 2018;68(4):510–4.
Mumtaz Lakhani states in her article, Lakhani, Mumtaz, Khurshid, M. O. H. A. M. M. E. D., Naqvi, S. H., & Akber, M. O. H. A. M. M. A. D. (1989). Neonatal screening for congenital hypothyroidism in Pakistan. JPMA. J Pak Med Assoc. 39(11), 282–284.
Jabbar A, Yawar A, Waseem S, Islam N, Ul Haque N, Zuberi L, Khan A, Akhter J. Vitamin B12 deficiency common in primary hypothyroidism. J Pak Med Assoc. 2008;58(5):258–61.
Karam GA, Hakimi H, Rezaeian M, Gafarzadeh A, Rashidinejad H, Khaksari M. Thyroid function in mothers who gave birth to neonates with transient congenital hypothyroidism. Pak J Med Sci. 2009;25(4):568–72.
Raza H, Riaz S, Jamal M, Shirazi H, Gul S. Congenital hypothyroidism-Newborn screening—the PIMS experience. Ann Pak Inst Med Sci. 2013;9(3):198–200.
Ghafoor F, Mohsin SN, Mukhtar S, Younas S, Hussain W. Newborn screening for congenital hypothyroidism in a public sector hospital. Pak J Med Res. 2013;52(2):39–42.
Anjum A, Afzal MF, Iqbal SMJ, Sultan MA, Hanif A. Indian J Endocrinol Metab. 2014;18(2):213–6. https://doi.org/10.4103/2230-8210.129114.
Ahmad A, Wasim A, Hussain S, Saeed M, Ahmad BMK. Congenital hypothyroidism in neonates of a tertiary care hospital. Pak J Med Sci. 2017;33(5):1269–72.
Tariq B, Ahmed A, Habib A, Turab A, Ali N, Soofi SB, Nooruddin S, Kumar RJ, Tariq A, Shaheen F, Ariff S. Assessment of knowledge, attitudes and practices towards newborn screening for congenital hypothyroidism before and after a health education intervention in pregnant women in a hospital setting in Pakistan. Int Health. 2018;10(2):100–7. https://doi.org/10.1093/inthealth/ihx069.
Ethics approval and consent to participate
Consent for publication
The authors declare that there is no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Mansoor, S. Trends of congenital hypothyroidism and inborn errors of metabolism in Pakistan. Orphanet J Rare Dis 15, 321 (2020). https://doi.org/10.1186/s13023-020-01602-6
- Metabolic disorders
- Inborn errors of metabolism